The PRR cGAS-STING was identified as a necessary upstream mediator in the type I IFN-dependent generation of endogenous antitumor immunity in immunogenic tumor types, identifying the downstream STING pathway as a critical bridge to activate cancer immunity. The gene discussed is STING1; the disease is neoplasm.